Anadarko Petroleum Corporation is an oil and gas exploration and production company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on APC’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Anadarko Petroleum could be a solid choice for investors.
Current Quarter Estimates for APC
In the past 30 days, three estimates have gone higher for Anadarko Petroleum while two have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 13 cents a share 30 days ago, to a loss of 7 cents per share today, a move of 46.2%.
Current Year Estimates for APC
Meanwhile, Anadarko Petroleum’s current year figures are also looking quite promising, with three estimates moving higher in the past month, compared to three lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $2.24 a share 30 days ago to a loss of $2.21 per share today, a move of 1.3%.
Anadarko Petroleum Corporation Price and Consensus
Bottom Line
The stock has also started to move higher lately, adding 16.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Image: Bigstock
Surging Earnings Estimates Signal Good News for Anadarko Petroleum (APC)
Anadarko Petroleum Corporation is an oil and gas exploration and production company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on APC’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Anadarko Petroleum could be a solid choice for investors.
Current Quarter Estimates for APC
In the past 30 days, three estimates have gone higher for Anadarko Petroleum while two have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 13 cents a share 30 days ago, to a loss of 7 cents per share today, a move of 46.2%.
Current Year Estimates for APC
Meanwhile, Anadarko Petroleum’s current year figures are also looking quite promising, with three estimates moving higher in the past month, compared to three lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from a loss of $2.24 a share 30 days ago to a loss of $2.21 per share today, a move of 1.3%.
Anadarko Petroleum Corporation Price and Consensus
Anadarko Petroleum Corporation Price and Consensus | Anadarko Petroleum Corporation Quote
Bottom Line
The stock has also started to move higher lately, adding 16.3% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>